Azra has obtained her Masters degree in Drug Discovery & Safety at VU University in Amsterdam, followed by a PhD at the Molecular Pharmacology group of Prof. Martine Smit at the same university. During her PhD she gained in depth knowledge of oncogenic signaling by human and viral chemokine receptors and targeting of these receptors by Nanobodies.

After her PhD she joined Janssen Vaccines as a Scientist in molecular and bioassay development for release, stability and characterization of clinical batches for vaccine candidates. After 6 years, in 2019 Azra joined Genmab as a Senior Scientist in bioassay development and functional characterization of antibody-based therapeutics in late stage clinical development as potential novel cancer treatments. Recently, Azra was promoted to Principal Scientist within the same focus area in the CMC Science and Technologies department at Genmab.